CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer
Authors
Al-Hajj
Althuis
+105 more
Asselin-Labat
Asselin-Labat
Bao
Bonnet
Cai
Cary
Cary
Chen
Chen
Chen
Chu
Cohen
Cohen
Cooper
Dalerba
Dean
Diehn
Dontu
Dunn
Dunty
Faraldo
Finn
Frisch
Golubovskaya
Guan
Guan
Han
Han
Hanahan
Hanks
Hennessy
Hsia
Hynes
Hynes
Kanner
Kaplan
Kiel
Kim
Klemke
Koebel
Kordon
Kornberg
Kouros-Mehr
Lahlou
Lapidot
Lark
Li
Li
Li
Li
Lietha
Lightfoot
Littlepage
Luo
Luo
Luo
Malanchi
McLean
McLean
Miranti
Mitra
Mitra
Mueller
Nagy
Naylor
O'Brien
Oktay
Owen
Owens
Parsons
Perry
Polte
Prince
Provenzano
Pylayeva
Reiske
Ren
Ricci-Vitiani
Rosen
Schaller
Schaller
Schaller
Schaller
Schlaepfer
Schlaepfer
Serrels
Shackleton
Sieg
Siesser
Singh
Smith
Stingl
Stingl
Stingl
Taddei
Taddei
van Nimwegen
Visvader
Vuori
Whitney
Wicha
Woodward
Wu
Wu
Xing
Publication date
1 January 2010
Publisher
'Wiley'
Doi
View
on
PubMed
Abstract
Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase identified as a key mediator of intracellular signaling by integrins, a major family of cell surface receptors for extracellular matrix, in the regulation of different cellular functions in a variety of cells. Upon activation by integrins through disruption of an autoinhibitory mechanism, FAK undergoes autophosphorylation and forms a complex with Src and other cellular proteins to trigger downstream signaling through its kinase activity or scaffolding function. A number of integrins are identified as surface markers for mammary stem cells (MaSCs), and both integrins and FAK are found to play crucial roles in the maintenance of MaSCs in studies using mouse models, suggesting that integrin signaling through FAK may serve as a functional marker for MaSCs. Consistent with previous studies linking increased expression and activation of FAK to human breast cancer, these findings suggest a novel cellular mechanism of FAK promotion of mammary tumorigenesis by maintaining the pools of MaSCs as targets of oncogenic transformation. Furthermore, FAK inactivation in mouse models of breast cancer also reduced the pool of mammary cancer stem cells (MaCSCs), decreased their self-renewal in vitro , and compromised their tumorigenicity and maintenance in vivo , suggesting a potential role of integrin signaling through FAK in breast cancer growth and progression through its functions in MaCSCs. This review discusses these recent advances and future studies into the mechanism of integrin signaling through FAK in breast cancer through regulation of MaCSCs that may lead to development of novel therapies for this deadly disease. © 2010 IUBMB IUBMB Life, 62(4): 268–276, 2010Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/69164/1/303_ftp.pd
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 22/03/2019
Deep Blue Documents
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:deepblue.lib.umich.edu:202...
Last time updated on 25/05/2012